Abstract
We have determined the frequency of deletion ΔF508 and mutation G542X, a nonsense mutation in exon 11 of the cystic fibrosis (CF) gene, in a sample of 400 Spanish CF families. Mutation G542X represents 8% of the total number of CF mutations in Spain, making it the second most common mutation after the ΔF508 deletion, which accounts for 48% of CF chromosomes. G542X has a higher frequency in the Mediterranean coastal area (14%) and in the Canary Islands (25%). About 70% of G542X chromosomes are from Andalucia, Múrcia, Valencia, Catalunya and the Canary Islands. The ΔF508 deletion has its highest frequency in the Basque Country (83%). Mutation G542X is associated with the same rare haplotype that is found in association with the ΔF508 mutation. The haplotype homogeneity found for G542X, even when intragenic microsatellites (IVS8CA, IVS17BTA and IVS17BCA) are considered, allows us to postulate that this mutation arose from a single mutational event. The geographic distribution of mutations ΔF508 and G542X suggests that ΔF508 was present in the Iberian Peninsula before the Indo-European invasions, and that G542X was introduced into Spain, via the Mediterranean Sea, probably by the Phoenicians, between 2500 and 3000 years ago.
Similar content being viewed by others
References
Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 2649–2680
Casals T, Nunes V, Lázaro C, Giménez FJ, Girbau E, Volpini V, Estivill X (1991) Mutation and linkage disequilibrium analysis in genetic counselling of Spanish cystic fibrosis families. J Med Genet 28:771–776
Casals T, Vazquez C, Lazaro C, Girbau E, Gimenez FJ, Estivill X (1992) Cystic fibrosis in the Basque Country: high frequency of mutation AF508 in patients of Basque origin. Am J Hum Genet 50:404–410
Chillón M, Nunes V, Casals T, Gimenez FJ, Fernandez E, Benitez J, Estivill X (1990) Distribution of ΔF508 mutation in 194 Spanish cystic fibrosis families. Hum Genet 85:396–397
Cuppens H, Marynen P, De Boeck C, De Baets F, Eggermont E, Van den Berghe H, Cassiman JJ (1990) A child homozygous for a stop codon in exon 11 shows milder cystic fibrosis symptoms than her heterozygous nephew. J Med Genet 27:717–719
Cutting GR, Kasch LM, Rosenstein BJ, Zielensky J, Tsui L-C, Antonarakis SE, Kazaian HH jr (1990) A cluster of cystic fibrosis mutations in the first nucleotide binding fold of the cystic fibrosis regulator protein. Nature 346:366–368
Cystic Fibrosis Genetic Analysis Consortium (1990) Worldwide survery of the ΔF508 mutation-report from the Cystic Fibrosis Genetic Analysis Consortium. Am J Hum Genet 47:354–359
Estivill X, Casals T, Morral N, Chillon M, Bosch A, Nunes V, Gasparini P, Savoia A, Pignatti PF, Novelli G, Dallapiccola B, Fernandez E, Benitez J, Williamson R (1989) ΔF508 gene deletion in Southern Europe. Lancet II:1404
Estivill X, Morral N, Casals T, Nunes V (1991) Prenatal diagnosis of cystic fibrosis using an intragenic microsatellite marker. Lancet 338:458
EWGCFG (1990) Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 85:436–441
Gasparini P, Bonizzato A, Dognini M, Pignatti PF (1992) Restriction site generating polymerase-chain reaction (RG-PCR) for the detection of hidden genetic variation: application to the study of some common CF mutations. Mol Cell Probes 6:1–7
Haliassos A, Chomel G, Tesson L et al. (1989) Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17:3606
Harrison RJ (1988) Spain at the dawn of hystory. Thames and Hudson. London
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC (1989) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Kerem B, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahaf J, Kennedy D, Riordan JR, Collins FC, Rommens JR, Tsui L-C (1990) Identification of mutations in regions corresponding to the two putative (ATP) binding folds of the cystic fibrosis gene. Proc Natl Acad Sci USA 87:8447–8451
Lerer I, Sagi M, Cutting GR, Abeliovich D (1991) Cystic fibrosis mutation G542X in Jewish patients. Am J Hum Genet 44:A397
Li CC (1976) First course in population genetics. Boxwood press, Pacific grove, Ca
Morral N, Nunes V, Casals T, Estivill X (1991) CA/GT microsatellites alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossing-over. Genomics 10:692–698
Morral N, Girbau E, Zielenski J, Nunes V, Casals T, Tsui L-C, Estivill X (1992) Dinucleotide (CA/GT) repeat polymorphism in intron 17B of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Hum Genet 88:356
Nunes V, Gasparini P, Novelli G et al. (1991) Analysis of 14 cystic fibrosis mutations in five South European populations. Hum Genet 87:737–738
Petit P (1962) Precis d'histoire ancienne. Presses Universitaires de France, Paris
Riordan J, Rommens J, Kerem B-S. Alon N, Rozmahel R, Grzelckak Z, Zielenski J, Lok S, Plavsik N, Chou J-L, Drumm M, Iannuzzi M, Collins F, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
Rommens J, Iannuzzi M, Kerem B-S, Drumm M, Melmer G, Dean M, Rozmahel R, Cole J, Kennedy D, Hidaka N, Ziga M, Buchwald M, Riordan J, Tsui L-C, Collins F (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1066
Rozen R, De Braekeleer M, Daigneault J, Ferreira-Rajabi L, Gerdes M, Lamoureaux L, Aubin G, Simard F, Fujiwara TM, Morgan K (1992) Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population which has an elevated incidence of cystic fibrosis. Am J Med Genet 42:360–364
Shoshani T, Basham N, Augarten A, Gazit E, Yahav J, Rivlin Y, Kerem E, Kerem B (1991) A termination mutation (W1282X). the most common mutation in the Jewish Ashkenazi CF patients in Israel, is associated with a severe disease presentation. Pediatr Pulmunol 56:242–243
Zielenski J, Rosmahel R, Bozon D, Kerem B-S, Grzelezak Z, Riordan JR, Rommens J, Tsui L-C (1991a) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator gene. Genomics 10:214–228
Zielenski J, Markiewicz D, Rinisland F, Rommens J, Tsui L-C (1991b) A cluster of highly polymorphic dinucleotide repeats in intron 17b of the CFTR gene. Am J Hum Genet 49:1256–1262
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Casals, T., Nunes, V., Palacio, A. et al. Cystic fibrosis in Spain: high frequency of mutation G542X in the Mediterranean coastal area. Hum Genet 91, 66–70 (1993). https://doi.org/10.1007/BF00230225
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00230225